Position in BNTX
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$373,296
-$26,544 QoQ
Shares Held
4,200
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Groupe la Francaise holds $42,995,507 across 10 Biotechnology names. BNTX ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
151,046 | $17,343,101 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
939,655 | $13,587,411 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
118,449 | $6,244,631 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
179,495 | $3,848,372 | |
| 5 | KZR |
Kezar Life Sciences, Inc.
|
80,400 | $596,568 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
|
29,698 | $397,062 | |
| 7 | BNTX |
BioNTech SE
This page
|
4,200 | $373,296 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
442 | $341,506 |
All Filings in BNTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $373,296 | 4,200 | Shares | Defined | 2026-05-21 | |
| 2025-12-31 | $399,840 | 4,200 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $462,034 | 4,685 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $447,174 | 4,200 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $382,452 | 4,200 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $478,590 | 4,200 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||